Nomad's Lens

Picture holding a pathology report full of words like "invasive," "poorly differentiated," and "lymphovascular invasion" — with no one to translate what any of it actually means for you. That gap between what's written and what's understood is called health literacy, and it may be one of the strongest predictors of how well someone survives cancer. Low health literacy isn't about intelligence. It's about systemic communication failures: rushed appointments, dense medical jargon, and...

Every new cancer drug, every breakthrough therapy, every treatment protocol that saves lives tomorrow — it all starts in a clinical trial today. Which raises an uncomfortable question: if certain communities are consistently left out of those trials, are we building tomorrow's medicine for everyone, or just for some? Clinical trial disparities occur when certain populations face lower participation, limited access, or reduced eligibility for cancer research. The consequences aren't abstract —...

Numbers rarely tell the whole story, and nowhere is that more true than in Indigenous cancer care. Indigenous peoples across First Nations, Inuit, and Métis communities often have lower cancer incidence than the general population — and yet face higher mortality. That contradiction is the story. It's not that Indigenous communities get more cancer. It's that when cancer arrives, it's too often caught late, treated in environments that don't feel safe, and unsupported by a healthcare system...